MAIA Biotechnology Inc.(MAIA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MAIA MAIA Biotechnology Inc.

Pre-Mkt 12-08 06:38:25 EST

1.20

+0.00

0.00%

High1.21	Low1.15	Vol241.78K
Open1.20	D1 Closing1.20	Amplitude4.99%
Mkt Cap44.44M	Tradable Cap34.01M	Total Shares37.03M
T/O286.31K	T/O Rate0.85%	Tradable Shares28.34M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MAIA","market":"US","secType":"STK","nameCN":"MAIA Biotechnology Inc.","latestPrice":1.2,"timestamp":1764968400000,"preClose":1.2,"halted":0,"volume":241775,"delay":0,"floatShares":28340000,"shares":37032307,"eps":-0.768287,"marketStatus":"Pre-Mkt","change":0,"latestTime":"12-08 06:38:25 EST","open":1.2,"high":1.2099,"low":1.15,"amount":286305.844825,"amplitude":0.049917,"askPrice":1.34,"askSize":100,"bidPrice":1.06,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.768287,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765204200000},"marketStatusCode":1,"adr":0,"listingDate":1659067200000,"exchange":"AMEX","adjPreClose":1.2,"postHourTrading":{"tag":"盘后","latestPrice":1.2,"preClose":1.2,"latestTime":"19:49 EST","volume":2115,"amount":2504.8943,"timestamp":1764982156550},"volumeRatio":0.19861481579627419},"requestUrl":"/m/hq/s/MAIA/tweets","defaultTab":"tweets","newsList":[{"id":"2588730867","title":"BRIEF-Maia Biotechnology Announces Open Market Purchases By CEO And Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2588730867","media":"Reuters","labels":["executive","shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588730867?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:18","pubTimestamp":1764598691,"startTime":"0","endTime":"0","summary":"BRIEF-Maia Biotechnology Announces Open Market Purchases By CEO And DirectorsDec 1 (Reuters) - Maia Biotechnology Inc MAIA.A:MAIA BIOTECHNOLOGY ANNOUNCES OPEN MARKET PURCHASES BY CEO AND DIRECTORSMAIA","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA9VSMFT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2588773741","title":"Maia Biotechnology Announces Open Market Purchases by CEO and Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2588773741","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588773741?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:17","pubTimestamp":1764598620,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA9VSMFT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2588744773","title":"Maia Biotechnology Inc - CEO Vlad Vitoc Purchases 94,300 Shares at $1.08 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2588744773","media":"THOMSON REUTERS","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588744773?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:17","pubTimestamp":1764598620,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA9VSMFT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2588737497","title":"Maia Biotechnology Inc - Board Members Purchase 88,145 Shares at $1.04 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2588737497","media":"THOMSON REUTERS","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588737497?lang=en_us&edition=fundamental","pubTime":"2025-12-01 22:17","pubTimestamp":1764598620,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA9VSMFT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2588721639","title":"Director Stan Smith Reports Acquisition of Common Shares in Maia Biotechnology Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2588721639","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588721639?lang=en_us&edition=fundamental","pubTime":"2025-12-01 19:15","pubTimestamp":1764587734,"startTime":"0","endTime":"0","summary":"Stan Smith, Director, has reported the acquisition of common shares of Maia Biotechnology Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maia Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL4x4DLk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Stan Smith Reports Acquisition of Common Shares in Maia Biotechnology Inc","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2587075677","title":"CEO’s Bold Move: Major Stock Purchase at MAIA Biotechnology!","url":"https://stock-news.laohu8.com/highlight/detail?id=2587075677","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587075677?lang=en_us&edition=fundamental","pubTime":"2025-11-29 10:02","pubTimestamp":1764381739,"startTime":"0","endTime":"0","summary":"New insider activity at MAIA Biotechnology, Inc. ( ($MAIA) ) has taken place on November 28, 2025. CEO Vlad Vitoc has made a significant move by pu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/ceos-bold-move-major-stock-purchase-at-maia-biotechnology-insider-trading-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/ceos-bold-move-major-stock-purchase-at-maia-biotechnology-insider-trading-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2586781650","title":"Director Cristian Luput Acquires Common Shares of Maia Biotechnology Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2586781650","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586781650?lang=en_us&edition=fundamental","pubTime":"2025-11-28 19:52","pubTimestamp":1764330756,"startTime":"0","endTime":"0","summary":"Cristian Luput, Director at Maia Biotechnology Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maia Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDL66ZGD0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Cristian Luput Acquires Common Shares of Maia Biotechnology Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2586684208","title":"Sarawak to Host the Inaugural Asia Pacific Aerospace Conference & Exhibition (APACE 2026) at BCCK","url":"https://stock-news.laohu8.com/highlight/detail?id=2586684208","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586684208?lang=en_us&edition=fundamental","pubTime":"2025-11-28 12:22","pubTimestamp":1764303720,"startTime":"0","endTime":"0","summary":"KUCHING, Malaysia, Nov. 28, 2025 /PRNewswire/ -- The Ministry of Education, Innovation and Talent Development Sarawak , in collaboration with Borneo Business Connect Sdn Bhd and supported by Business Events Sarawak , today announced the launch of the inaugural Asia Pacific Aerospace Conference & Exhibition . The event will take place from 27–29 January 2026 at the Borneo Convention Centre Kuching .APACE 2026 is a strategic initiative of the Sarawak State Government to position Sarawak as a rising hub for aerospace, aviation, and advanced technology within Southeast Asia. Held under the theme \"Navigating the Future of Aerospace: Innovation, Sustainability and Growth,\" the event is designed to catalyse international collaboration and connect global aerospace stakeholders, industry leaders, innovators, and educational institutions with the rapidly expanding opportunities emerging across the region.Hosted by MEITD, APACE 2026 is strongly supported by multiple ministries and agencies, inclu","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2833984/DSC02345.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2833984/DSC02345.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/sarawak-to-host-the-inaugural-asia-pacific-aerospace-conference--exhibition-apace-2026-at-bcck-302627880.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4217","HST","BK4082","MOTS","BK4139","MAIA","BK4218","SMA","BK4588","SDEC","BK4181","EPU","BK4585"],"gpt_icon":0},{"id":"2586529817","title":"Maia Biotechnology Director Stan Smith Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586529817","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586529817?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:44","pubTimestamp":1764193473,"startTime":"0","endTime":"0","summary":"Stan Smith, Director of Maia Biotechnology Inc., reported the acquisition of common shares of Maia Biotechnology Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maia Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 26, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL52Ztxq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Maia Biotechnology Director Stan Smith Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2586091654","title":"Maia Biotechnology CEO Vlad Vitoc Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586091654","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586091654?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:16","pubTimestamp":1764105372,"startTime":"0","endTime":"0","summary":"Vlad Vitoc, Chief Executive Officer of Maia Biotechnology Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maia Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 25, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL424851:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Maia Biotechnology CEO Vlad Vitoc Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2585146039","title":"MAIA Biotechnology highlights momentum of ateganosine clinical program","url":"https://stock-news.laohu8.com/highlight/detail?id=2585146039","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585146039?lang=en_us&edition=fundamental","pubTime":"2025-11-21 22:10","pubTimestamp":1763734231,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology (MAIA) announced highlights from two poster presentations delivered at SITC 2025, an annual conference hosted by the Society for...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-highlights-momentum-of-ateganosine-clinical-program-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-highlights-momentum-of-ateganosine-clinical-program-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2585014987","title":"MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2585014987","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585014987?lang=en_us&edition=fundamental","pubTime":"2025-11-21 22:01","pubTimestamp":1763733660,"startTime":"0","endTime":"0","summary":"Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as expansion trial adds new countries Posters for Phase 2 and Phase 3 clinical trials available CHICAGO , Nov.  21, 2025  (GLOBE NEWSW","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/21/3192819/0/en/MAIA-Biotechnology-Highlights-Ongoing-Momentum-of-Ateganosine-Clinical-Program-at-SITC-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BYQNZ168.SGD","BK4081","BK4585","BK1541","OS","MAIA","IE00BYTNYN87.SGD","BK4588","BK4139","IE00B12V2V27.USD","CPI","IE0003851619.USD","BK1103","L","IE0003795394.USD","BK4097","BK4107","LU0053666078.USD","LU2487616109.SGD","LU0210528500.USD","SG9999011746.SGD","01308","EMA","ORR"],"gpt_icon":0},{"id":"2584158835","title":"MAIA Biotechnology Expands Phase 2 Study in Romania","url":"https://stock-news.laohu8.com/highlight/detail?id=2584158835","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584158835?lang=en_us&edition=fundamental","pubTime":"2025-11-20 22:30","pubTimestamp":1763649034,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology, Inc. ( ($MAIA) ) has shared an announcement. On November 20, 2025, MAIA Biotechnology announced that its CEO, Vlad Vitoc, prese...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maia-biotechnology-expands-phase-2-study-in-romania?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maia-biotechnology-expands-phase-2-study-in-romania?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2584013203","title":"MAIA Biotechnology CEO presents at Smart Diaspora 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2584013203","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584013203?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:55","pubTimestamp":1763646924,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology (MAIA) announced a presentation by CEO Vlad Vitoc, M.D. at Smart Diaspora 2025, a conference dedicated to advancing oncology res...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-ceo-presents-at-smart-diaspora-2025-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-ceo-presents-at-smart-diaspora-2025-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2584913273","title":"MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Romania’s 2025 Smart Diaspora Conference on Oncology Research and Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2584913273","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584913273?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:47","pubTimestamp":1763646420,"startTime":"0","endTime":"0","summary":"Company starts enrollment in Romania for Phase 2 THIO-101 Part C study of ateganosine as a treatment for advanced non-small cell lung cancer patients CHICAGO, Nov.  20, 2025  (GLOBE NEWSWIRE) -- MAIA ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/20/3191938/0/en/MAIA-Biotechnology-CEO-Presents-Telomere-Targeting-Efficacy-at-Romania-s-2025-Smart-Diaspora-Conference-on-Oncology-Research-and-Innovation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2487616109.SGD","CPI","BK4107","ORR","MAIA","LU0053666078.USD","BK4139","LU0210528500.USD","BK4588","BK4585","L"],"gpt_icon":0},{"id":"2578622869","title":"MAIA Biotechnology’s Innovative Approach in NSCLC Treatment: A Phase 2 Study Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2578622869","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578622869?lang=en_us&edition=fundamental","pubTime":"2025-10-28 02:15","pubTimestamp":1761588921,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology, Inc. (($MAIA)) announced an update on their ongoing clinical study. MAIA Biotechnology, Inc. is conducting a Phase 2 clinical s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maia-biotechnologys-innovative-approach-in-nsclc-treatment-a-phase-2-study-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maia-biotechnologys-innovative-approach-in-nsclc-treatment-a-phase-2-study-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2578288966","title":"MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2578288966","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578288966?lang=en_us&edition=fundamental","pubTime":"2025-10-27 22:45","pubTimestamp":1761576300,"startTime":"0","endTime":"0","summary":"First five patients in Part C (expansion) of THIO-101 Phase 2 clinical trial enrolled in Taiwan and Turkey CHICAGO, Oct.  27, 2025  (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/27/3174761/0/en/MAIA-Biotechnology-Presents-Trial-in-Progress-Poster-at-the-2025-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210528500.USD","LU0572940350.SGD","LU0053666078.USD","PRGS","LU2065732104.USD","BK4211","BK4539","01336","LU2487616109.SGD","BK4585","BK1584","LU0264606111.USD","BK4007","NIC","BK1184","NCI","BK4107","BK4202","ORR","BK1550","CPI","BK4097","LENZ","MAIA","BK4139","BK4588","L","LU0572939691.SGD"],"gpt_icon":0},{"id":"2577588180","title":"MAIA Biotechnology Showcases Promising Cancer Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2577588180","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577588180?lang=en_us&edition=fundamental","pubTime":"2025-10-23 21:47","pubTimestamp":1761227277,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology, Inc. ( ($MAIA) ) just unveiled an announcement. On October 23, 2025, MAIA Biotechnology announced the presentation of two e-pos...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maia-biotechnology-showcases-promising-cancer-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maia-biotechnology-showcases-promising-cancer-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2577304780","title":"MAIA Biotechnology details 30-month patient survival in Phase 2 trial of NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2577304780","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577304780?lang=en_us&edition=fundamental","pubTime":"2025-10-23 20:40","pubTimestamp":1761223252,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology (MAIA) announced highlights from a recent presentation at the European Society for Medical Oncology, ESMO, Congress 2025 held in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-details-30-month-patient-survival-in-phase-2-trial-of-nsclc-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-details-30-month-patient-survival-in-phase-2-trial-of-nsclc-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2577304942","title":"Maia Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2577304942","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577304942?lang=en_us&edition=fundamental","pubTime":"2025-10-23 20:36","pubTimestamp":1761222960,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nTUA6TML2Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.maiabiotech.com","stockEarnings":[{"period":"1week","weight":0.0169},{"period":"1month","weight":0.0619},{"period":"3month","weight":-0.2208},{"period":"6month","weight":-0.3333},{"period":"1year","weight":-0.3939},{"period":"ytd","weight":-0.3939}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.189243},{"month":2,"riseRate":0,"avgChangeRate":-0.060346},{"month":3,"riseRate":0.333333,"avgChangeRate":0.091126},{"month":4,"riseRate":0.666667,"avgChangeRate":0.190738},{"month":5,"riseRate":0.666667,"avgChangeRate":0.134126},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.131471},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.058081},{"month":8,"riseRate":0,"avgChangeRate":-0.148704},{"month":9,"riseRate":0.25,"avgChangeRate":0.000086},{"month":10,"riseRate":0.25,"avgChangeRate":-0.039628},{"month":11,"riseRate":0.25,"avgChangeRate":-0.189158},{"month":12,"riseRate":0.5,"avgChangeRate":0.007882}],"exchange":"AMEX","name":"MAIA Biotechnology Inc.","nameEN":"MAIA Biotechnology Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MAIA Biotechnology Inc.(MAIA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MAIA Biotechnology Inc.(MAIA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MAIA Biotechnology Inc.,MAIA,MAIA Biotechnology Inc.股票,MAIA Biotechnology Inc.股票老虎,MAIA Biotechnology Inc.股票老虎国际,MAIA Biotechnology Inc.行情,MAIA Biotechnology Inc.股票行情,MAIA Biotechnology Inc.股价,MAIA Biotechnology Inc.股市,MAIA Biotechnology Inc.股票价格,MAIA Biotechnology Inc.股票交易,MAIA Biotechnology Inc.股票购买,MAIA Biotechnology Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MAIA Biotechnology Inc.(MAIA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MAIA Biotechnology Inc.(MAIA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}